EntrepreneurialCheck
Matthew Kane estimated net worth profile

Matthew Kane net worth

Matthew Kane Net Worth 2026 (Estimated) · Founder at Pirouette Pharma · YC S21
est. wealth $6.67M

Quick answer

Matthew Kane's estimated net worth is $6.67M (range $4.67M – $10.0M) as of 2026. Matthew Kane is Founder at Pirouette Pharma. Pirouette Pharma valuation.

Matthew Kane is Founder at Pirouette Pharma (YC S21). Independent Entrepreneurial Check model estimate from public YC data.

At a glance

NameMatthew Kane
RoleFounder
CompanyPirouette Pharma
YC batchS21
Est. company val$20.0M
Assumed ownership33.3%
Est. paper wealth / net worth$6.67M
$4.67M – $10.0M
  • Company status: Active
  • Education: MBA from Harvard Business School; BS from University of Pennsylvania.
  • Region: United States of America
  • Industries: Healthcare, Drug Discovery and Delivery
  • Team size: 9
  • Website: https://www.pirouettepharma.com/

Who is Matthew Kane?

Matthew Kane is a founder of Pirouette Pharma, a biotechnology company that focuses on developing treatments for rare diseases.

Highlights:

  • University of Pennsylvania
  • Harvard Business School
  • Y Combinator S21

About Pirouette Pharma

At Pirouette, we have developed a low-profile, disk-shaped, rugged injection device with a patient-centric focus on affordability, portability, and usability. The patented device, based on extensive patient input, is designed to make administering an injection as easy as pushing a button. This allows individuals with limited or no training to easily and intuitively perform an injection on themselves or others.

FAQ: Matthew Kane net worth and Pirouette Pharma valuation

What is Matthew Kane's net worth?

Matthew Kane's estimated net worth is $6.67M (range $4.67M – $10.0M) as of 2026. Matthew Kane is Founder at Pirouette Pharma. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.

What is Pirouette Pharma valuation?

Pirouette Pharma's estimated valuation on Entrepreneurial Check is $20.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.

What is Matthew Kane's role?

Matthew Kane is Founder at Pirouette Pharma, a Y Combinator-backed startup (batch S21).